HIGHLIGHTS
- who: Hui Li and colleagues from the University of Zurich, Switzerland have published the research: Identification of a novel RMST-ALK rearrangement in advanced lung adenocarcinoma and durable response to ceritinib: A case report, in the Journal: (JOURNAL)
- what: The authors report a novel case of RMST-ALK rearrangement in NSCLC with a durable response to ceritinib.
- future: Functional studies and clinical follow-up are required.
SUMMARY
Lung cancer is currently the third most common cancer worldwide (12.3% of all cancer diagnoses) and the leading cause of cancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.